A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents
Clinical trial NCT02517892 · COMPLETED
Trial details
- NCT number
- NCT02517892
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-18
- Primary completion
- 2025-03-01
- Enrollment
- 1500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.